Metoprolol vs Atenolol: Beta Blocker Comparison

Beta blockers remain a cornerstone of cardiovascular treatment, and the metoprolol vs atenolol comparison comes up frequently because these two medications are among the most prescribed in their class. Both are selective beta-1 blockers that primarily target the heart, slowing heart rate and reducing blood pressure. However, they differ in important ways, including how the body processes them, their evidence base for specific conditions, and their side effect profiles. These differences can significantly affect treatment outcomes and daily quality of life.

According to the CDC, heart disease is the leading cause of death in the United States, and beta blockers are prescribed to tens of millions of Americans. Whether you are starting a new prescription or considering a switch, understanding how these two medications compare will help you have a more productive conversation with your cardiologist. Our medical conditions guide covers many of the conditions these medications treat.

Most important safety point first: never stop a beta blocker suddenly. Abruptly discontinuing metoprolol or atenolol can trigger a dangerous rebound — a rapid heart rate, a spike in blood pressure, worsening chest pain (angina), and in some cases a heart attack or dangerous rhythm. If you and your doctor decide to stop or switch, it should be done as a gradual, prescriber-directed taper, never on your own. This is a warning carried in the FDA prescribing information for these drugs.

How Metoprolol and Atenolol Work

Both metoprolol and atenolol are cardioselective (beta-1 selective) blockers, meaning they preferentially block beta-1 receptors found predominantly in heart tissue. By blocking these receptors, they reduce heart rate, decrease the force of heart contractions, and lower blood pressure. They also reduce the heart’s demand for oxygen, which is why they are valuable in managing angina and post-heart attack care.

Cardioselectivity is important because it means these medications are less likely to affect beta-2 receptors in the lungs and blood vessels compared to non-selective beta blockers like propranolol. This makes them relatively safer options for some patients with mild asthma or COPD, though caution is still warranted and the decision belongs to a clinician. According to the National Library of Medicine, this beta-1 selectivity decreases at higher doses — which is true for both medications, so “cardioselective” does not mean “risk-free” for people with reactive airway disease.

Key Differences at a Glance

Note: the values above describe pharmacology, not a treatment plan. Actual dosing and dosing frequency are individualized and are set by your prescriber — this article intentionally does not provide doses.

Effectiveness for High Blood Pressure

Both medications effectively lower blood pressure. However, current guidelines from the American College of Cardiology and American Heart Association no longer recommend beta blockers as first-line treatment for uncomplicated hypertension. ACE inhibitors, ARBs, calcium channel blockers, and thiazide diuretics are generally preferred. Beta blockers are now recommended primarily when hypertension coexists with another condition they treat, such as heart failure, post-heart attack care, or certain arrhythmias.

A notable difference emerged from the MERIT-HF trial, which showed that metoprolol succinate (extended-release) reduced mortality in patients with heart failure with reduced ejection fraction. Atenolol lacks comparable heart failure evidence and is generally not recommended for this indication. This distinction is one of the most clinically important differences in the metoprolol vs atenolol comparison.

Effectiveness for Other Heart Conditions

Post-Heart Attack (Secondary Prevention)

Metoprolol has stronger evidence for post-heart attack use. Multiple large trials have demonstrated that metoprolol reduces the risk of repeat cardiac events after a myocardial infarction. The Mayo Clinic lists post-MI care as one of metoprolol’s primary indications. Atenolol was commonly used for this purpose in the past but has weaker trial data supporting a mortality benefit.

Arrhythmias

Both medications help control heart rate in atrial fibrillation and other supraventricular tachycardias by slowing conduction through the AV node. In clinical practice, metoprolol is more commonly reached for in acute hospital settings (an intravenous form exists), while either drug may be used for chronic rate control depending on the patient.

Angina

Both metoprolol and atenolol are effective for stable angina, reducing the frequency and severity of chest pain episodes by lowering the heart’s workload. For migraine prevention, metoprolol has more supporting data, though both have been used off-label for this purpose.

Side Effect Comparison

The side effect profiles of these two beta blockers overlap significantly, but a few meaningful differences exist due to their chemical properties.

Central nervous system effects: Because metoprolol is lipophilic (fat-soluble), it crosses the blood-brain barrier more readily than the water-soluble atenolol. This means metoprolol may be somewhat more likely to cause vivid dreams, sleep disturbances, low mood, and fatigue. Patients who experience significant CNS side effects on metoprolol sometimes do better on atenolol — but that is a change to discuss with a prescriber, not to make alone. For a comprehensive look at metoprolol’s side effects, see our guide to metoprolol side effects.

Common side effects shared by both: Fatigue and tiredness (the most frequent complaint), dizziness, cold hands and feet, slow heart rate (bradycardia), and sometimes gastrointestinal symptoms. Sexual dysfunction, including erectile dysfunction, can occur with both drugs.

Diabetes and low blood sugar: This is an important safety caution. Beta blockers can mask the early warning signs of hypoglycemia — such as a racing heart and tremor — so people with diabetes who use insulin or other glucose-lowering medicines should monitor blood sugar closely and know that sweating may still occur even when other warning signs are blunted. MedlinePlus specifically notes this risk with metoprolol.

Kidney and liver considerations: Atenolol is primarily eliminated through the kidneys, so dosing must be adjusted by a prescriber in patients with impaired kidney function. Metoprolol is processed by the liver, which can make it a preferred choice for some patients with significant kidney disease; conversely, metoprolol should be used cautiously in people with significant liver disease.

Bradycardia and asthma/COPD: Both drugs can slow the heart too much, so they are used cautiously — or avoided — in people who already have a very slow or unstable heart rhythm. And while cardioselectivity makes them safer than older non-selective beta blockers for people with airway disease, they can still provoke bronchospasm in susceptible patients, so asthma and COPD are important things to disclose to your prescriber.

When to seek emergency care: Call 911 or go to the nearest emergency room if you experience a very slow heart rate with dizziness or fainting, severe difficulty breathing or wheezing, chest pain that is new or worsening, or signs of an allergic reaction including swelling of the face, lips, or throat.

Drug Interactions

Metoprolol is metabolized by the CYP2D6 enzyme in the liver, making it susceptible to interactions with drugs that inhibit this enzyme. Common CYP2D6 inhibitors such as fluoxetine (Prozac), paroxetine (Paxil), and bupropion (Wellbutrin) can increase metoprolol blood levels, potentially causing excessive slowing of the heart rate and drops in blood pressure.

Atenolol’s renal elimination means it has fewer metabolic drug interactions, which can be an advantage for patients taking multiple medications. Both drugs interact with certain calcium channel blockers (particularly verapamil and diltiazem), clonidine, and other heart-rate-lowering medications. Neither should be combined with these drugs without careful medical supervision — and clonidine in particular should also never be stopped abruptly alongside a beta blocker.

Frequently Asked Questions

Can I switch from atenolol to metoprolol?

Switching between these beta blockers is common, but it should always be done under medical supervision and by a prescriber, who will choose the appropriate medication and dose for your situation. Because the two drugs are not milligram-for-milligram equivalent and beta blockers should never be stopped abruptly, do not attempt to convert or substitute on your own — talk to your cardiologist or primary care doctor about the safest way to make a change.

Which beta blocker is better for anxiety?

Neither metoprolol nor atenolol is FDA-approved for anxiety. Propranolol (a non-selective beta blocker) is more commonly used off-label for performance or situational anxiety. Any use of a beta blocker for anxiety-related symptoms should be directed by a clinician.

Do beta blockers cause weight gain?

Beta blockers can cause modest weight gain, particularly in the first few months of treatment, thought to result from a reduced metabolic rate and lower exercise tolerance. Some newer beta blockers such as carvedilol and nebivolol may cause less, though data are mixed. Do not change or stop your medication over weight concerns without talking to your doctor.

Can I exercise while taking metoprolol or atenolol?

Yes, but both medications lower your maximum heart rate, which can feel like a ceiling on exercise intensity. Many people gauge effort using perceived exertion rather than a heart-rate target while on a beta blocker. Most people adjust within a week or two — but check with your doctor before starting a vigorous new program.

What happens if I miss a dose or run out?

Because stopping suddenly is risky, do not simply let the prescription lapse. If you miss a dose, follow the guidance your pharmacist or prescriber gave you, and if you are about to run out, contact your prescriber or pharmacy for a refill rather than stopping. Rebound effects are exactly what the “never stop abruptly” warning is meant to prevent.

What to Do Next

The metoprolol vs atenolol decision depends largely on your specific condition and health history. If you have heart failure, metoprolol succinate is the better-supported choice based on mortality data. If you are sensitive to CNS side effects like vivid dreams or fatigue, atenolol may be more tolerable for some people. For patients with kidney problems, metoprolol’s liver metabolism can be advantageous, while atenolol’s fewer drug interactions may benefit patients on many medications. These are conversations to have with your prescriber, not decisions to make alone.

If you are currently taking either medication and experiencing bothersome side effects, bring up the possibility of switching at your next appointment. Do not stop or change your dose without medical guidance — abruptly discontinuing a beta blocker can cause dangerous rebound increases in heart rate and blood pressure and can trigger angina or a heart attack. Both medications are affordable, effective, and well-established, so the choice between them is often about finding the best individual fit. For related reading, see our article on symptoms of heart failure.

Sources

• MedlinePlus — Metoprolol
• MedlinePlus — Atenolol
• FDA / DailyMed — metoprolol tartrate and succinate; atenolol prescribing information (warning against abrupt discontinuation)
• American Heart Association — beta blockers, heart failure, and blood pressure
• ACC/AHA 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure
• MERIT-HF trial — metoprolol succinate in heart failure with reduced ejection fraction